Research and regulations regarding medical marijuana are constantly evolving. Advanced practice RNs (APRNs) caring for patients who may use cannabis need a knowledge base and guidance for practice. During her session on April 29, 2021, for the 46th Annual ONS Congress™, Kathleen Russell, JD, MN, RN, associate director of nursing regulation at the National Council of State Boards of Nursing (NCSBN), reviewed key points from NCSBN’s Guidelines for the Nursing Care of Patients Using Marijuana that are particularly relevant to oncology APRNs.
“Nature alone cures,” Florence Nightingale instructed her fellow nurses in Notes on Nursing—and we’ve continued to follow that principle, creating a healing environment for our patients that involves fresh air and sunlight. That same environment can promote health in nurses as well.
Altering a patient's gut microbiome through fecal transplant improved response to immune checkpoint inhibitor therapy in 40% of patients with advanced melanoma who initially did not respond to the immunotherapy in a small, single-arm clinical trial. Researchers reported the findings in Science.
As health care has made countless adaptations to forge on during the COVID-19 coronavirus pandemic, oncology nurse researchers haven’t escaped the effects. During a session on April 27, 2021, for the 46th Annual ONS Congress™, Kathleen Calzone, PhD, RN, AGN-BC, FAAN, and Donna Berry, PhD, RN, AOCN®, FAAN, outlined specific ways researchers have pivoted with virtual approaches to continue their important work.
Even before the COVID-19 coronavirus pandemic’s push to virtual in almost every aspect of society, the trend away from traditional lecture-style learning and toward more interactive learning was well underway. The approach helps busy learners better understand, retain, and apply concepts in fast-paced and ever-changing environments, such as the field of oncology, Renee Davis, MSN, RN, NPD-BC, from ProDevo Design and Consulting, said on April 27, 2021, during a session for the 46th Annual ONS Congress™.
Radionuclides, also called radioisotopes, are unstable chemical elements that release radiation as they break down, and that action can be combined with cancer drugs to fight tumors with a new punch. During a session on April 27, 2021, for the 46th Annual ONS Congress, Pam Grubbs, APRN, CNS, MS, AOCNS®, of Mayo Clinic in Rochester, MN, discussed how oncology is using radiopharmaceuticals in a variety of ways.
When the COVID-19 coronavirus pandemic pushed oncology research to a remote, virtual format, the sudden adjustment was, in many ways, more convenient and more effective, but it also posed several challenges. During a presentation on April 27, 2021, for the 46th Annual ONS Congress™, two nurse researchers shared the lessons they learned when they adjusted their research protocols.
For the findings to be usable, healthcare research clinical trials must accrue participants that accurately represent the general population to which the study applies. But that’s easier said than done. During a session on April 27, 2021, for the 46th Annual ONS Congress™, two oncology nurse scientists shared strategies that other researchers can use to overcome disparities in clinical trial study populations.
In a highly technical environment, radiation oncology nurses’ role on the interprofessional team is both critical and flourishing. But it’s also ever-evolving, speakers explained during a session on April 27, 2021, for the 46th Annual ONS Congress™.
On December 18, 2020, the U.S. Food and Drug Administration approved relugolix (OrgovyxTM) as the first oral hormone therapy for use in adult patients with advanced prostate cancer.